Patent · US Active

HSV antigenic peptides and HSV protein vaccines

US11160860B2 · kind B2 · utility

0Cited by
2References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 25, 2018
Grant dateNov 2, 2021
Priority date—
Expiry dateMay 2, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/20234
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

HSV glycoprotein B-VSV-G1 fusion proteins and variants thereof, HSV glycoprotein C antigenic peptide constructs and variants thereof, HSV immunogenic compositions and protein vaccines including the peptide constructs, and HSV DNA vaccines encoding the amino acid sequence of the peptide constructs, as well as methods of using the vaccines and compositions comprising the vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.